Evidence map›Paper›PMID 32762496›Full record

ArticleCirculation research2020

Parallel Murine and Human Plaque Proteomics Reveals Pathways of Plaque Rupture.

Tomáš Vaisar, Jie H Hu, Nathan Airhart, Kate Fox, Jay Heinecke, Roberto F Nicosia, Ted Kohler, Zachary E Potter, Gabriel M Simon, Melissa M Dix and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Circulation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Tomáš Vaisar *Departments of Medicine (T.V., J.H.H., N.A., K.F., J.H., S.A.G., D.A.D.), University of Washington, Seattle.
Jie H Hu *Departments of Medicine (T.V., J.H.H., N.A., K.F., J.H., S.A.G., D.A.D.), University of Washington, Seattle.
Nathan AirhartDepartments of Medicine (T.V., J.H.H., N.A., K.F., J.H., S.A.G., D.A.D.), University of Washington, Seattle.
Kate FoxDepartments of Medicine (T.V., J.H.H., N.A., K.F., J.H., S.A.G., D.A.D.), University of Washington, Seattle.
Jay HeineckeDepartments of Medicine (T.V., J.H.H., N.A., K.F., J.H., S.A.G., D.A.D.), University of Washington, Seattle.
Roberto F NicosiaDepartments of Pathology and Laboratory Medicine (D.A.D., R.F.N.), University of Washington, Seattle.
Ted KohlerDepartments of Surgery (T.K.), University of Washington, Seattle.
Zachary E PotterDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA (Z.E.P., M.M.D., B.F.C.).
Gabriel M SimonVividion Therapeutics (G.M.S.).
Melissa M DixDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA (Z.E.P., M.M.D., B.F.C.).
Benjamin F CravattDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA (Z.E.P., M.M.D., B.F.C.).
Sina A Gharib *Departments of Medicine (T.V., J.H.H., N.A., K.F., J.H., S.A.G., D.A.D.), University of Washington, Seattle.
David A Dichek *Departments of Medicine (T.V., J.H.H., N.A., K.F., J.H., S.A.G., D.A.D.), University of Washington, Seattle.
University of Washington · USScripps Research Institute · USVividion Therapeutics (United States) · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1986 to 2026
$41.4M
Project 3 - HDL Structure/Function in LCAT Deficient HumansP01HL128203 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI W Sean Davidson · 2016 to 2026
$25.1M
Role of Serum Amyloid A in Diabetic Vascular DiseaseP01HL092969 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E. · 2008 to 2019
$23.5M
Integrated Multi-omics of MelioidosisR01AI137111 · NIAID · UNIVERSITY OF WASHINGTON · PI GHARIB, SINA A, WEST, TIMOTHY EOIN · 2018 to 2021
$3.2M
Structural basis for cardioprotective HDLR01HL149685 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E., HEINECKE, JAY W · 2020 to 2023
$2.8M
A proteomic approach for understanding plaque ruptureR21HL113405 · NHLBI · UNIVERSITY OF WASHINGTON · PI DICHEK, DAVID A · 2012 to 2013
$441k
NHLBI NIH HHS P01 HL092969NHLBI NIH HHS P01 HL128203NHLBI NIH HHS R01 HL149685NHLBI NIH HHS R21 HL113405NIAID NIH HHS R01 AI137111NIDDK NIH HHS P30 DK017047
6 · The paper itself

Abstract

rationalePlaque rupture is the proximate cause of most myocardial infarctions and many strokes. However, the molecular mechanisms that precipitate plaque rupture are unknown.

objectiveBy applying proteomic and bioinformatic approaches in mouse models of protease-induced plaque rupture and in ruptured human plaques, we aimed to illuminate biochemical pathways through which proteolysis causes plaque rupture and identify substrates that are cleaved in ruptured plaques. METHODS AND

resultsWe performed shotgun proteomics analyses of aortas of transgenic mice with macrophage-specific overexpression of urokinase (SR-uPA

conclusionsParallel studies of SR-uPA

Indexed as

Plaque, AtheroscleroticProteomeProteomicsAgedAged, 80 and overAnimalsAortaAortic DiseasesAtherosclerosisCarotid ArteriesCarotid Artery DiseasesComputational BiologyDisease Models, AnimalFemaleHumansMaleProteomeReceptors, ScavengerUrokinase-Type Plasminogen Activatorbasement membranecardiovascular diseasesendarterectomyextracellular matrixproteomics

Identifiers

PMID32762496
PMCPMC7508285
OpenAlexW3045905919

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.